“…The risk of mortality of those diseases associated with Type D is 4-fold, with this risk being independent of disease severity, traditional biomedical risk factors and mood states . Type D personality seems not just to be a phenomenon that is relevant to patients with coronary heart disease, where the construct was initially developed, but also in patients with chronic heart failure (Schiffer, Pedersen, Broers, Widdershoven & Denollet, 2008;Schiffer, Pedersen, Widdershoven, Hendriks, Winter & Denollet, 2005), peripheral arterial disease , and in patients treated with state-of-the-art invasive treatment, including percutaneous coronary intervention with drug-eluting stents (van Gestel, Pedersen, van de Sande, de Jaegere, Serruys, Erdman et al, 2007;Spindler, Pedersen, Serruys, Erdman & van Domburg, 2007;Pedersen, Denollet, Ong, Serruys, Erdman & van Domburg, 2007;Denollet, Pedersen, Ong, Erdman, Serruys & van Domburg, 2006) and device therapy (Pedersen, Van Domburg, Theuns, Jordaens & Erdman, 2004;Pedersen, Theuns, Muskens-Heemskerk, Erdman & Jordaens, 2007). NA and SI were not predictive of outcome individually; only the joint presence of high scores on both dimensions was linked to disease morbidity and mortality (Habra, Linden, Anderson, Weinberg, 2003).…”